Related Experiment Video
Updated: Oct 30, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Leg ulcers in sickle cell disease patients
Paula Dadalti Granja1, Samuel Braulio Magalhães Quintão1, Franciele Perondi1
1Departamento de Medicina Clínica - MMC, Faculdade de Medicina, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil.
Sickle cell leg ulcers are common, slow-healing skin sores in sickle cell disease patients. This review covers their presentation, causes, and treatment strategies.
Area of Science:
- Hematology
- Dermatology
- Vascular Medicine
Background:
- Leg ulcers are the most frequent skin complication in sickle cell disease (SCD).
- These ulcers predominantly affect individuals with homozygous SCD (HbSS).
- The lesions are characterized by slow healing and frequent recurrence, leading to significant patient burden.
Purpose of the Study:
- To comprehensively review the clinical presentation of sickle cell leg ulcers.
- To discuss the diagnostic approaches for these chronic wounds.
- To explore the underlying pathophysiology and treatment implications.
Main Methods:
- Literature review of clinical studies, case reports, and reviews on sickle cell leg ulcers.
- Analysis of pathophysiology, clinical manifestations, and therapeutic interventions.
- Synthesis of current knowledge on diagnosis and management.
Main Results:
- Sickle cell leg ulcers present with characteristic features and are often misdiagnosed.
- Pathophysiology involves vaso-occlusion, chronic inflammation, and impaired wound healing.
- Treatment requires a multidisciplinary approach, addressing underlying SCD and wound care.
Conclusions:
- Early recognition and accurate diagnosis are crucial for effective management.
- Understanding the pathophysiology guides tailored treatment strategies.
- Improved management can mitigate the physical, emotional, and economic impact on patients.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease

